The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation.

BACKGROUND: There is no single definitive test to identify prostate cancer in men. Biopsies are commonly used to obtain samples of prostate tissue for histopathological examination. However, this approach frequently misses cases of cancer, meaning that repeat biopsies may be necessary to obtain a di...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Health Technol Assess
Päätekijät: Nicholson, Amanda, Mahon, James, Boland, Angela, Beale, Sophie, Dwan, Kerry, Fleeman, Nigel, Hockenhull, Juliet, Dundar, Yenal
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: NIHR Journals Library 2015
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4780983/
https://ncbi.nlm.nih.gov/pubmed/26507078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta19870
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia